Xencor, Inc.
TARGETED IL-12 HETERODIMERIC FC-FUSION PROTEINS
Last updated:
Abstract:
The present invention relates to targeted IL-12 heterodimeric Fc fusion proteins, where the fusion proteins bind to human PD-1 or human PD-L1.
Status:
Application
Type:
Utility
Filling date:
2 Oct 2020
Issue date:
18 Nov 2021